Response Genetics Inc (RGDXQ)
0.00
USD |
OTCM |
Apr 24, 16:00
Response Genetics Cash from Operations (TTM): -13.09M for March 31, 2015
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2015 | -11.12M |
December 31, 2014 | -12.34M |
September 30, 2014 | -13.19M |
June 30, 2014 | -11.52M |
March 31, 2014 | -10.29M |
December 31, 2013 | -8.075M |
September 30, 2013 | -6.985M |
June 30, 2013 | -4.490M |
March 31, 2013 | -5.455M |
December 31, 2012 | -8.011M |
September 30, 2012 | -8.257M |
June 30, 2012 | -9.175M |
March 31, 2012 | -6.524M |
December 31, 2011 | -5.084M |
September 30, 2011 | -4.605M |
Date | Value |
---|---|
June 30, 2011 | -4.599M |
March 31, 2011 | -6.750M |
December 31, 2010 | -6.492M |
September 30, 2010 | -7.424M |
June 30, 2010 | -8.185M |
March 31, 2010 | -8.914M |
December 31, 2009 | -8.414M |
September 30, 2009 | -9.002M |
June 30, 2009 | -9.908M |
March 31, 2009 | -8.836M |
December 31, 2008 | -6.791M |
September 30, 2008 | -4.952M |
June 30, 2008 | -3.470M |
March 31, 2008 | -1.378M |
December 31, 2007 | -3.486M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
Perspective Therapeutics Inc | -36.91M |
Electromed Inc | 4.872M |
Xtant Medical Holdings Inc | -9.515M |
Asensus Surgical Inc | -63.63M |
Vitro Biopharma Inc (DELISTED) | -2.820M |